Holen Sie sich die Stockscreener-App
41.99
2.53%
-1.09
Handel nachbörslich:
41.98
-0.01
-0.02%
Spruce Biosciences Inc Aktie (SPRB) Neueste Nachrichten
Spruce Biosciences (SPRB) gains 9.1% shareholder group led by AIGH - Stock Titan
Spruce Biosciences Welcomes Adrian Quartel as Chief Medical Officer - Contract Pharma
Spruce Biosciences, Inc. Files Form 8-K: Company Details, Nasdaq Listing, and Corporate Information (July 2026) - Minichart
Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer - Investing News Network
Spruce Biosciences appoints Adrian Quartel as chief medical officer - Investing.com
Spruce Biosciences (NASDAQ: SPRB) names Adrian Quartel as chief medical officer - Stock Titan
SPRB|Spruce Biosciences Inc|Price:43.080|Chg%:-1.910 - TradingKey
Spruce Biosciences Inc (SPRB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Spruce Biosciences Inc (SPRB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Spruce Biosciences Inc (SPRB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Spruce Biosciences Inc (SPRB) Balance Sheet - TradingKey
Spruce Biosciences Inc (SPRB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Spruce Biosciences Inc (SPRB) Valuation: PE, PB & Fair Value Analysis - TradingKey
SPRB|Spruce Biosciences Inc|Price:43.260|Chg%:-1.730 - TradingKey
Spruce Biosciences Inc (SPRB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
SPRB Stock Drops After Company Pushes Back Application Submission Timeline For Experimental Sanfilippo Syndrome Therapy - Stocktwits
Certain Warrants of Spruce Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 20-JUL-2026. - marketscreener.com
Certain Restrcied Stock Units of Spruce Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 20-JUL-2026. - marketscreener.com
Spruce Biosciences (SPRB) Corporate presentation Summary - Quartr
Spruce Biosciences (SPRB) AGM 2026 Summary - Quartr
Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme - The National Law Review
B. Riley Securities Initiates Spruce Biosciences(SPRB.US) With Buy Rating, Announces Target Price $160 - Moomoo
SPRB Initiates Coverage On B. Riley Securities -- Buy Rating Ass - GuruFocus
B.Riley initiates Spruce Biosciences stock with buy rating on therapy potential - Investing.com Nigeria
B.Riley initiates Spruce Biosciences stock with buy rating on therapy potential By Investing.com - Investing.com South Africa
Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs - AOL.com
Form 4 Spruce Biosciences Inc For: 9 July By Investing.com - Investing.com Nigeria
Spruce Biosciences (SPRB) Leerink Global Healthcare Conference 2026 Summary - Quartr
Spruce Biosciences Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesPre-Earnings Setup - DonanımHaber
Spruce Biosciences (SPRB) CEO adds 266 shares through employee stock purchase plan - Stock Titan
Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit - Business Wire
Spruce Biosciences Possibly First In-MPS IIIB Class Enzyme Replacement Therapy - Seeking Alpha
Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller - AOL.com
Spruce Biosciences (SPRB) Holds Steady Near Resistance After Flat SessionBuffered ETF - dars.gov.et
Price to book forward of Spruce Biosciences, Inc. – NASDAQ:SPRB - TradingView
Spruce Biosciences (SPRB) Joins Russell 3000 Index - GuruFocus
Spruce Biosciences Joins the Russell 3000® Index - BioSpace
Spruce Biosciences, Inc.(NasdaqCM:SPRB) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 2500 Growth Benchmark - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 2000 Index - marketscreener.com
Spruce Biosciences added to Russell 3000 index By Investing.com - Investing.com South Africa
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 2000 Value Benchmark - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM:SPRB) added to Russell Microcap Value Benchmark Index - marketscreener.com
Spruce Biosciences added to Russell 3000 index - Investing.com
Spruce Biosciences, Inc.(NasdaqCM:SPRB) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 3000E Growth Benchmark - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell Microcap Index - marketscreener.com
ETFs Investing in Spruce Biosciences, Inc. Stocks - TradingView
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 3000 Growth Benchmark - marketscreener.com
Price to sales forward of Spruce Biosciences, Inc. – BOATS:SPRB - TradingView
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 3000E Value Benchmark - marketscreener.com
Spruce Biosciences Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock RallyEarnings Beat Streak - dars.gov.et
Enterprise value to EBIT forward of Spruce Biosciences, Inc. – BOATS:SPRB - TradingView
Enterprise value to EBITDA forward of Spruce Biosciences, Inc. – BOATS:SPRB - TradingView
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):